Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,004 public trials 1,759 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

NCT02097056

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Ansan, Gyeonggi-do, South Korea

Buchoen, Gyeonggi-do, South Korea

Seongnam-si, Gyeonggi-do, South Korea

Jinju, Gyeongsangnam-do, South Korea

View all 13 locations

View Trial Details

Completed

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease

NCT02424708

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Bastyr University Kenmore, Washington, United States

University of Washington Seattle, Washington, United States

View Trial Details

Completed

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NCT02298270

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

African American Alzheimer's Progression Markers - CSF and Neuro-Imaging

NCT02089555

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Emory University Atlanta, Georgia, United States

View Trial Details

Completed

Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects

NCT01520987

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Covance Clinical Research Unit, Inc. Honolulu, Hawaii, United States

View Trial Details

Completed

Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease

NCT01429909

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Chu Clermont-Ferrand Clermont-Ferrand, France

View Trial Details

Completed

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

NCT00742417

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
Locations: Howard University Washington D.C., District of Columbia, United States

Mid-Atlantic Geriatric/ARC Whiting, New Jersey, United States

Fundació ACE Barcelona, Catalonia, Spain

Hospital General Universitario Gregorio Marañon Madrid, Spain

View Trial Details

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

NCT02778594

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Human Pharmacology Unit S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Resveratrol for Alzheimer's Disease

NCT01504854

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +14 more
Locations: Banner Alzheimer's Institute Phoenix, Arizona, United States

University of California, Irvine Irvine, California, United States

University of California, San Diego - Comprehensive Alzheimer's Program La Jolla, California, United States

University of Southern California Los Angeles, California, United States

View all 26 locations

View Trial Details

Completed

Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention

NCT01802554

Conditions: Alzheimer Disease, Behavior, Behavioral Symptoms, +17 more
Locations: University of California San Diego La Jolla, California, United States

View Trial Details

Neurodegenerative Diseases

Neurodegenerative Diseases trial results

Related conditions